Homology Medicines: Q4 Earnings Snapshot
By AP News
Published - Mar 09, 2023, 05:51 PM ET
Last Updated - Jun 22, 2023, 05:02 PM EDT
BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Homology Medicines Inc. (FIXX) on Thursday reported a loss of $34.3 million in its fourth quarter.
The Bedford, Massachusetts-based company said it had a loss of 60 cents per share.
The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 51 cents per share.
The gene editing company posted revenue of $802,000 in the period.
